Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 803 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.37 USD | -2.99% | +2.75% | +12.49% | +115.78% | 11.88 B USD | ||
| 837 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 59.65 USD | -1.16% | +2.95% | +3.90% | +2.23% | 11.53 B USD | ||
| 857 |  TECH Bio-Techne Corp - Common Stock | 70.56 USD | -0.07% | -0.24% | +32.04% | +33.36% | 11.05 B USD | ||
| 864 |  KRYS Krystal Biotech, Inc. - Common Stock | 365.13 USD | -0.94% | -2.49% | +18.94% | +95.12% | 10.76 B USD | ||
| 872 |  ABVX Abivax SA - American Depositary Shares | 137.77 USD | -3.09% | +2.82% | +35.87% | +1637.33% | 10.82 B USD | ||
| 887 |  CYTK Cytokinetics, Incorporated - Common Stock | 82.54 USD | -3.53% | -2.70% | +20.32% | +42.07% | 10.27 B USD | ||
| 908 |  CORT Corcept Therapeutics Incorporated - Common Stock | 91.49 USD | -2.71% | +0.73% | +23.62% | +24.70% | 9.82 B USD | ||
| 927 |  NUVL Nuvalent, Inc. - Class A Common Stock | 123.81 USD | +0.03% | +0.17% | +0.81% | +30.39% | 9.78 B USD | ||
| 928 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 118.87 USD | -0.31% | +3.05% | +58.75% | +101.13% | 9.78 B USD | ||
| 944 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 79.32 USD | -2.76% | +4.34% | +10.20% | +18.74% | 9.41 B USD | ||
| 965 |  IBRX ImmunityBio, Inc. - Common Stock | 8.64 USD | -1.37% | -3.14% | +18.36% | +214.18% | 9.05 B USD | ||
| 974 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 136.27 USD | -3.25% | +10.05% | +38.35% | +81.38% | 8.76 B USD | ||
| 977 |  TGTX TG Therapeutics, Inc. - Common Stock | 56.68 USD | -2.38% | +2.98% | +33.40% | +57.49% | 8.68 B USD | ||
| 978 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 318.11 USD | -1.80% | -2.45% | +23.29% | +567.32% | 8.87 B USD | ||
| 984 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.50 USD | -0.04% | +113.17% | +147.26% | +103.16% | 8.80 B USD | ||
| 999 |  PCVX Vaxcyte, Inc. - Common Stock | 57.13 USD | -5.83% | +1.76% | +21.73% | +35.06% | 8.25 B USD | ||
| 1017 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 63.26 USD | -5.99% | +0.05% | +27.33% | +59.55% | 7.91 B USD | ||
| 1018 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.53 USD | -0.01% | +0.59% | +59.57% | +149.17% | 8.27 B USD | ||
| 1022 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 90.69 USD | -3.76% | +3.44% | +24.28% | +279.30% | 7.88 B USD | ||
| 1024 |  IMVT Immunovant, Inc. - Common Stock | 38.97 USD | -2.79% | +2.28% | +24.03% | +102.86% | 8.00 B USD |
Notícias Biotechnology Stocks
BofA mantém recomendação de compra para Beam Therapeutics após decisão arbitral
Dinamarca - Ações fecharam o pregão em queda e o Índice OMX Copenhagen 20 recuou 1,33%
‘Por que a CVM não viu isso antes?’
Por que as ações da Beam Therapeutics estão caindo hoje?
Por que as ações da Prime Medicine estão disparando hoje?
Ação da Incyte atinge máxima de 52 semanas em US$ 118,77
Ações da Prime Medicine disparam após vitória em arbitragem contra a Beam
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |